Evidence map›Paper›PMID 31772819›Full record

ReviewAmerican journal of nuclear medicine and molecular imaging2019

SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

Luis Michel Alonso Martinez, François Harel, Myriam Létourneau, Vincent Finnerty, Alain Fournier, Jocelyn Dupuis, Jean N DaSilva

Open access · greenAbstract readReview
In one paragraph

Review in American journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Luis Michel Alonso MartinezUniversity of Montreal Hospital Research Centre Montréal (Québec), Canada.
François HarelDepartment of Biomedical Engineering, Faculty of Medicine, Université de Montréal Montréal (Québec), Canada.
Myriam LétourneauLaboratoire D'Études Moléculaires Et Pharmacologiques Des Peptides, INRS-Centre Armand-Frappier Santé Biotechnologie Laval (Québec), Canada.
Vincent FinnertyResearch Center of The Montreal Heart Institute Montréal (Québec), Canada.
Alain FournierLaboratoire D'Études Moléculaires Et Pharmacologiques Des Peptides, INRS-Centre Armand-Frappier Santé Biotechnologie Laval (Québec), Canada.
Jocelyn DupuisResearch Center of The Montreal Heart Institute Montréal (Québec), Canada.
Jean N DaSilvaUniversity of Montreal Hospital Research Centre Montréal (Québec), Canada.
Montreal Heart Institute · CAInstitut National de la Recherche Scientifique · CAMontreal General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating adrenomedullin (AM) levels are elevated in several cardiovascular diseases, including pulmonary vascular diseases causing pulmonary hypertension. To date the perfusion agent

Indexed as

adrenomedullin radiotracerslung microcirculationPETPulmonary arterial hypertensionpulmonary embolismSPECT

Identifiers

PMID31772819
PMCPMC6872478
OpenAlexW2995339916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.